{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} HPV Vaccination for Prevention of Head and Neck Cancer Among Men

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the current incidence of HPV-associated HNC among men.
  2. Explain the history of HPV vaccination recommendations for males and reasons for HPV vaccine hesitancy.
  3. Describe recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) for HPV vaccine administration.

Learning Outcomes

Seventy-five percent of participants will be able to demonstrate knowledge gained about the incidence of human papillomavirus (HPV)-related head and neck cancer (HNC) among men and vaccination recommendations for prevention purposes by achieving a posttest score of 70% or greater.
Price: $21.95

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: NP1023B
Published: Oct 2023
Expires: 12/6/2024
Required Passing Score: 7/10 (70%)
Authors: Mohamed Toufi c El Hussein, PhD, RN, NP; Simreen Dhaliwal